FDA’s Overhaul Of GMP Oversight Will Include Numerous Targeted Guidances
Executive Summary
FDA is developing an ad hoc guidance process for manufacturing issues through which it will issue short recommendations based on specific circumstances
You may also be interested in...
NDA Reviews Will Be Risk-Based Under FDA Good Manufacturing Initiative
The Center for Drug Evaluation & Research will apply a risk-based approach in considering manufacturing issues in reviewing NDAs, Office of Compliance Director David Horowitz said
NDA Reviews Will Be Risk-Based Under FDA Good Manufacturing Initiative
The Center for Drug Evaluation & Research will apply a risk-based approach in considering manufacturing issues in reviewing NDAs, Office of Compliance Director David Horowitz said
FDA Dispute Resolution Process Should Be Less Structured, Merck Exec Says
Industry wants FDA's dispute resolution process to allow for less structured interaction during the appeals process, Merck Manufacturing Quality Assurance Director David Haggard said